Abstract:The title compound, C(22)H(22)N(2)O(10), was prepared by the glycosidation method through nitrite displacement on substituted nitro-phthalonitrile. The mol-ecule contains a benzene ring, two nitrile groups and an acetyl-protected d-glucose fragment which adopts a chair conformation. The absolute configuration was determined by the use of d-glucose as starting material. All substituents of the protected sugar are in equatorial positions, with the exclusive presence of the α-anomer. The crystal packing is stabilized by C-H⋯O and C-H⋯N hydrogen-bonding inter-actions.

5-Phenyl-1,3,4-thiadiazol-2-yl 2,3,4,6-Tetra-o-acetyl-1-thio-beta-d-glucopyranoside

2-Acetylamino-1,3,4,6-tetra-o-(trimethylsilyl)-2-deoxy-α-d-glucopyranose

2-Acetyl-amino-1,3,4,6-tetra-O-(tri-methyl-silyl)-2-de-oxy-α-d-gluco-pyran-ose.

1-Phenylethyl Phenyldithioacetate

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

2,2′-Diamino-4,4′-bi-1,3-thiazol-3,3′-diium Bis(2,2′-Diamino-4,4′-bi-1,3-thiazol-3-ium) Tetrakis(2-Nitrobenzoate)

3,4-Dicyanophenyl 2,3,4,6-Tetra-o-acetyl-α-d-glucopyranoside

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

3,4-Dicyanophenyl 2,3,4,6-tetra-<i>O</i>-acetyl-α-<scp>D</scp>-glucopyranoside

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

4-Methoxyphenyl 2,3,4,6-Tetra-O-Acetyl-Beta-D-Galactopyranoside

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

5-(4-Phenoxyphenyl)-1,3,4-thiadiazol-2-amine

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

2,3,4,6-Tetra-o-acetyl-1-o-(4-methoxy-cinnamo-yl)-β-d-glucopyran-ose.

4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidine-2-thione

Methyl 7-(4-bromophenyl)-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carbo Xylate